glp 1 health concerns The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 How GLP-1 Medications Boost Weight

Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes: a systematic review and meta-analysis

, founder of the Comite Center for Precision Medicine & Health previously told Prevention

Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction

Interestingly, its been shown that combining metformin with vitamin D seems to enhance the positive effects of metformin, including reducing thyroid antibodies, improving insulin sensitivity, and improving thyroid hormone levels

Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice

Semaglutide and tirzepatide were not designed to affect hair, but the way they work indirectly puts hair follicles at risk